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Abstract
Background: Carpal tunnel syndrome (CTS) is a common peripheral neuropathy and ischemic-reperfusion injury.
Oxidative stress is considered a major cause of CTS. Linalool, a component of essential oils, has antioxidant activity.
This study was designed to determine the effects of linalool inhalation on oxidative stress in patients with CTS.
Methods: This double-blind, placebo-controlled study assessed the effects of linalool inhalation on oxidative stress
in patients with CTS. Thirty-seven subjects, with and without CTS, were randomized to inhalation of 1 % linalool or
carrier oil. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity, systolic blood pressure (sBP), diastolic
blood pressure (dBP) and pulse rate were analyzed.
Results: DPPH inhibition was significantly higher in both experimental groups than in their respective controls.
Moreover inhalation of linalool reduced sBP, dBP and pulse rate in the CTS group, and pulse rate in the non-CTS group.
However, there were no significant differences among the study groups in nitrite levels, sBP, dBP and pulse rate.
Conclusions: Inhalation of linalool increases antioxidative activity and reduces blood pressure and pulse rate in
patients with CTS.
Keywords: Carpal tunnel syndrome, Linalool, Antioxidative activity
Background
Carpal tunnel syndrome (CTS) is one of the most com-
monly observed neuropathies. CTS is typically caused by
compression of the median nerve at the wrist due to ele-
vated tunnel pressure [1]. Such compression may be asso-
ciated with repeated trauma caused by work, pregnancy or
type 2 diabetes, but in most patients CTS is idiopathic [2].
Ischemia-reperfusion injury in subsynovial connective tis-
sue may also cause CTS [3]. Reactive oxygen species
(ROS) derived from oxidative stress contribute to tissue
injury, and may therefore cause and exacerbate CTS [4].
Oxidative stress in subsynovial connective tissue has been
associated with CTS. Moreover, the subjective symptoms
of CTS were found to be triggered by oxidative stress and
activation of proinflammatory cytokines [5]. In addition,
oxidative stress level and antioxidant activity were found
to be altered in patients with CTS [6].
Patients with CTS experience pain, numbness and
tingling and functional deficits in the wrist and hand
that affect their daily life [1]. Severe CTS may result in
weakness in the affected hand, frustration or inability
related to motor deficits [7]. Non-surgical interventions
in patients with CTS include analgesics, splinting and
steroid injections, although surgery may be required in
patients with intractable or severe diseases. Injection of
steroids results in significant symptom relief, but it is
unfit for long-term therapy [8]. Splinting the wrist re-
duces pressure on the median nerve, but its effect on
long-term symptoms is unclear [9]. Due to the limita-
tions of these conservative treatments, additional inter-
ventions are required for the symptomatic relief of
patients with CTS.
Linalool, a monoterpene alcohol, is a component of
many natural aromatic plants. Linalool has been
found to have biological activities, including analgesic,
anti-inflammatory and antioxidant effects. The anti-
inflammatory effects of linalool in lung cells have been
associated with the modulation of pro-inflammatory cy-
tokines and antioxidant enzymes. In particular, linalool
reduced the levels of nuclear factor-erythroid 2, a regu-
lator of antioxidant stress [10]. In addition, linalool was
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found to be effective as an antioxidant in guinea pig
brains injected with H2O2 [11], one of the major
reagents used in antioxidant studies. Also, in male Wis-
tar rats, linalool decreased oxidative stress by modulat-
ing malondialdehyde, a marker for lipid peroxidation
and increased glutathione content [12]. Moreover, linal-
ool had an analgesic effect in an animal model of acute
pain induced by paclitaxel, a widely used chemotherapy
agent [13]. The antioxidant properties of linalool sug-
gested it may have beneficial effects in patients with
CTS. This study therefore assessed the effects of linalool
inhalation on antioxidant activity in patients with CTS.
Methods
Study design and patient population
The effects of linalool on antioxidative activity in patients
with carpal-tunnel syndrome were assessed using a pretest-
posttest control group study design. Healthy adults with no
underlying disease (non-CTS group) were recruited. In
addition, patients with CTS diagnosed by electrodiagnostic
tests (CTS group) who were scheduled for outpatient sur-
gery at the Center for Plastic and Reconstructive Surgery in
Seoul, Korea, were recruited. Each subject was randomly
assigned to inhale linalool or carrier oil. Adequate sample
size was determined using the G-Power program. Based on
a statistical power of 0.50, an effect size of 0.40, and a
significance level of 0.05, the minimum number of total pa-
tients required to compare differences between the experi-
mental groups was estimated to be 41 patients.
After the study protocol was approved by the Ethical
Review Committee of the Korea University Medical
Center’s approval (Code: ED12257), subjects were re-
cruited for 18 months, starting in June 2013. In addition
to providing written informed consent for study partici-
pation, all subjects were required to have no history of
psychiatric illness, no disturbances of olfactory acuity, no
experience with aromatherapy and to be free of allergies to
linalool. Patients with CTS were diagnosed by a registered
physician and had not undergone surgery. After exclusion
of participants who dropped out of the study, 37 individuals
completed the study (14/37 non-CTS group with linalool;
6/37 non-CTS group with carrier; 11/37 CTS group with
linalool; and 6/37 CTS group with carrier).
Intervention
Linalool was purchased from Sigma (St. Louis, MO,
USA) and almond oil was obtained from Aromarant Co.
Ltd. (Rottingen, Germany). Linalool was dissolved in al-
mond oil at a concentration of 1 %. A 0.5 mL aliquot of
1 % linalool in almond oil (or almond oil alone) was
placed onto a gauze pad (3 × 2 cm2), and the pad was
positioned five centimeters from the nose of each sub-
ject for 10 min, with the subject in a sitting position
after deep breathing. Before the intervention, general
characteristics, blood pressure and heart rates were mea-
sured. After the intervention, blood samples were col-
lected and blood pressure and heart rates were measured.
Blood pressure and pulse rate measurements
Blood pressure and heart rate as indicators of the re-
sponse of the autonomic nervous system were measured
before and after linalool or carrier oil inhalation. Blood
pressure was measured in the right brachial artery after
a 10-min rest in a sitting position. Heart rate was mea-
sured at the radial artery for 1 min.
Assay of 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical
scavenging activity
Plasma concentrations of the radical scavenger 1,1-
diphenyl-2-picrylhydrazyl (DPPH) were measured. Blood
samples (3 mL) were obtained from each participant
after inhalation and centrifuged at 3500 rpm for 10 min
at 4 °C to separate the plasma. The samples were stored
at −80 °C until assayed. Proteins were removed by mix-
ing plasma and acetonitrile at a 1:1 ratio, incubating the
samples at room temperature for 2 min, and centrifuging
the samples at 9500 × g for 10 min at 4 °C. The resultant
supernatants were diluted five-fold with ethanol. DPPH in
anhydrous ethanol was mixed 1:1 with Tris HCL and added
to 96 well plates, to which were added plasma supernatants.
Ascorbic acid was used as the standard antioxidant. The 96
well plates were incubated in the dark at 37 °C for 30 min,
and the absorbances of the solutions were measured spec-
trophotometrically at 517 nM using a microplate reader.
The percentage of scavenging activity was compared with
that obtained in the sample of ascorbic acid.
DPPH free radical scavenging activity (%) was defined
as (1-sample absorbance/control absorbance)*100.
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware (version 12.0). Participants’ characteristics at base-
line were explored using Fisher’s exact test. A Shapiro-
Wilk test was applied to evaluate data normality, and
differences among groups were tested by the Kruskal-
Wallis test or one-way analysis of variance (ANOVA).
Within group differences in scores before and after in-
terventions were compared using the Wilcoxon’s rank-
sum test. All data were reported as mean ± standard de-
viation (SD), with P-values < .05 considered statistically
significant.
Results
Characteristics of study population
Thirty seven women were screened for eligibility and
participated in the study. Mean subject age was
59.9 years; the general characteristics of the participants
are shown in Table 1. At baseline, the demographic and
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disease-related characteristics of the groups were
similar, including body mass index (BMI) and treat-
ments with antihypertensive and analgesic agents
(Table 2).
Effects of linalool on the DPPH radical scavenging activity
Mean DPPH radical-scavenging activities in plasma sam-
ples from the non-CTS control, non-CTS linalool, CTS
control and CTS linalool groups were 10.40 ± 3.08 %,
30.38 ± 1.32 %, 16.32 ± 3.39 %, and 27.36 ± 1.82 %, re-
spectively (Fig. 1). Differences among the 4 groups were
analyzed by one-way ANOVA followed by Tukey’s post
hoc test. DPPH radical scavenging activity was higher in
the CTS linalool groups compared with their respective
CTS control groups (P = 0.031) and in non-CTS linalool
groups compared with their respective control groups
(P < 0.001).
Table 1 General characteristics of the subjects
Characteristics non-CTS Control n (%) non-CTS Linalool n (%) CTS Control n (%) CTS Linalool n (%) P-valuea
Age (years) 0.570
41–50 1 (16.7) 1 (7.1) 1 (16.7) 1 (9.1)
51–60 1 (16.7) 5 (35.7) 2 (33.3) 6 (54.5)
61–70 4 (66.7) 8 (57.1) 2 (33.3) 3 (27.3)
≥ 71 0 (0) 0 (0) 1 (16.7) 1 (9.1)
Gender
Male 0 (0) 0 (0) 0 (0) 0 (0)
Female 6 (100) 14 (100) 6 (100) 11 (100)
Marriage 0.324
Yes 6 (100) 14 (100) 5 (83.3) 11 (100)
No 0 (100) 0 (0) 1 (16.2) 0 (0)
Occupation 0.138
Housewife 6 (100) 9 (64.3) 4 (66.7) 8 (72.7)
Other 0 (0) 5 (35.7) 2 (33.4) 3 (27)
BMI (kg/m2) 0.465
< 18.5 1 (16.7) 6 (42.9) 1 (16.7) 5 (45.5)
18.5 ~ 23.0 4 (66.7) 8 (57.1) 5 (83.3) 5 (45.5)
> 23.0 1 (16.7) 0 (0) 0 (0) 1 (9.1)
Menopause 0.053
Yes 5 (83.3) 14 (100) 5 (83.3) 7 (63.6)
No 1 (16.7) 0 (0) 1 (16.7) 4 (36.4)
Analgesics
Yes 0 0 (0) 0 (0) 0 (0)
No 6 (100) 14 (100) 6 (100) 11 (100)
Antihypertensive drug 0.250
Yes 3 (50) 3 (21.4) 0 (0) 2 (18.2)
No 3 (30) 11 (78.6) 6 (100) 9 (81.8)
aBy Fisher’s exact test. CTS, carpal tunnel syndrome
Table 2 Homogeneity test for measurement variables among four groups at pretest
Variables non-CTS Control non-CTS Linalool CTS Control CTS Linalool P-valuea
sBP 125.00 ± 10.49 120.00 ± 9.61 130.00 ± 8.94 124.55 ± 15.08 0.267
dBP 78.33 ± 7.53 74.29 ± 7.56 79.67 ± 5.72 79.09 ± 5.39 0.221
Pulse rate 71.50 ± 8.71 75.00 ± 8.38 86.67 ± 12.75 70.36 ± 10.61 0.065
Data presented as mean ± standard deviation
T-VAS tingling visual analogue scale, sBP systolic blood pressure, dBP diastolic blood pressure, CTS carpal tunnel syndrome
aAnalyzed using Kruskal-Wallis test
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Effects of linalool on blood pressure and heart rate
Following inhalation of linalool, both systolic (P = 0.004)
and diastolic (P = 0.025) blood pressure significantly de-
creased from baseline in subjects with CTS, but there
were no differences among the four groups (Table 3).
Inhalation of linalool significantly reduced heart rate
compared with baseline in both the non-CTS linalool
(P = 0.004) and CTS linalool (P = 0.017) groups, al-
though there were no significant differences among the
four groups after inhalation.
Discussion
The principal aim of this study was to evaluate the effi-
cacy of linalool as an antioxidant in patients with CTS.
We hypothesized that linalool would enhance oxidative
defenses in healthy adults. Indeed, we found that inhal-
ation of linalool by subjects with no underlying disease
significantly improved antioxidant activity, in agreement
with previous results showing that linalool decreased tis-
sue injury evoked by oxidative stress in rats [14].
Oxidative stress is characterized by an imbalance be-
tween generation and removal of ROS, and has been
shown to contribute to the pathogenesis of various dis-
eases throughout the body [15]. The cumulative effect of
ROS from ischemia reperfusion on the flexor tenosyno-
vium and subsynovial connective tissue has been found
to lead to CTS [3]. Similarly, the pro-inflammatory cyto-
kine activator nuclear factor κB (NF-κB) and transform-
ing growth factor were found to be elevated in patients
with CTS. Moreover, the level of oxidative stress corre-
lated with the degree of subjective symptoms [5], with
both antioxidant activity and oxidative stress altered in
patients with CTS [6]. We therefore evaluated the effects
of linalool on DPPH radical scavenging activity in sub-
jects without underlying disease and in individuals with
Fig. 1 Effects of linalool inhalation on DPPH among four groups
after treatment. Results presented as mean ± standard error of the
mean, with differences compared by one-way ANOVA followed by
Tukey’s post hoc test. *P < 0.05 compared with CTS control group.
###P < 0.001 compared with non-CTS control group. CTS, carpal
tunnel syndrome
Table 3 Difference in dependent variables between four groups after treatment
Variables non-CTS Control non-CTS Linalool CTS Control CTS Linalool P-valuea
sBP
Pre-test 125.00 ± 10.49 120.00 ± 9.61 130.00 ± 8.94 124.55 ± 15.08
Post-test 121.67 ± 9.83 117.14 ± 10.69 128.33 ± 9.83 114.55 ± 16.95
Difference 3.33 ± 13.66 2.86 ± 10.69 1.67 ± 17.22 10.00 ± 8.94 0.237
P-valueb 0.576 0.336 0.822 0.004
dBP
Pre-test 78.33 ± 7.53 74.29 ± 7.56 79.67 ± 5.72 79.09 ± 5.39
Post-test 81.67 ± 9.83 72.14 ± 8.93 78.33 ± 9.83 73.64 ± 9.24
Difference −3.33 ± 5.16 2.14 ± 8.02 1.33 ± 11.08 5.45 ± 6.88 0.192
P-valueb 0.175 0.336 0.780 0.025
Pulse rate
Pre-test 71.50 ± 8.71 75.00 ± 8.38 86.67 ± 12.75 70.36 ± 10.61
Post-test 69.83 ± 4.83 71.36 ± 7.98 85.33 ± 11.64 65.55 ± 8.80
Difference 1.67 ± 6.22 3.64 ± 0.97 1.33 ± 5.32 4.82 ± 5.60 0.435
P-valueb 0.540 0.004 0.566 0.017
Data presented as mean ± standard deviation
T-VAS tingling visual analogue scale, sBP systolic blood pressure, dBP diastolic blood pressure, CTS carpal tunnel syndrome
aDifferences among groups analyzed using the Kruskal-Wallis test
bWithin group differences analyzed using Wilcoxon’s rank-sum test
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CTS. We observed significant relationships between lin-
alool and antioxidant level, not only in subjects without
underlying disease but in patients with CTS. These re-
sults therefore indicated that inhalation of linalool en-
hanced antioxidant activity, regardless of the presence of
increased oxidative stress. These findings, along with a
report showing that linalool effectively decreased NF-κB
in diabetic rats [16], suggest that linalool may be used to
treat symptoms in patients with CTS.
Linalool is a natural compound with numerous
pharmacological activities, acting not only as an antioxi-
dant but as a cardiovascular modulator, analgesic and
antianxiety agent. Transdermal absorption of linalool re-
duced blood pressure in healthy subjects compared with
a control group, with no side effects [17]. Moreover, lin-
alool was found to reduce heart rate and stably alter
mood status in healthy volunteers [18]. In rats and mice,
linalool decreased blood pressure by modulating blood
vessels [19, 20], and was reported to have sedative or
anxiolytic-like effects in mice [21]. Similarly, we con-
firmed that linalool decreased heart rate and blood pres-
sure in subjects with CTS.
CTS is a common chronic condition. Subjects usually
experience sensory changes, including tingling and
numbness. Symptoms may continue or worsen, with
subjects experiencing sharp pain and weakness, and
eventually complaining of reduced ability or frustration
related to motor deficits [7]. Therefore, linalool may re-
lieve symptoms and enhance emotional stability in pa-
tients with CTS.
Current interventions for CTS result in partial symp-
tom relief and are not effective in all patients. Therefore,
there is a need to develop additional treatments. Inhal-
ation therapy is non-invasive and simple, suggesting that
it may be a new option for patients with CTS.
Conclusion
Our results indicate that inhalation of linalool increased
antioxidative activity not only in healthy adults but also
in CTS patients, and reduced blood pressure and pulse
rate in CTS patients. These findings suggest that linalool
may be a useful additional intervention in these patients.
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